Birdwatch Archive

Birdwatch Note Rating

2023-03-17 20:04:49 UTC - NOT_HELPFUL

Rated by Participant: 45B8EF43682258D990F1C39DD9C1C131E030B7B116A1A874CAD37AED55F98C04
Participant Details

Original Note:

The puberty blocker Lupron was never approved for gender-affirming care: it was trialled and approved by the FDA for precocious puberty in 6-8 year old girls. There are currently no peer-reviewed long-term studies on the effects of blockers on sexual function and fertility. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020263s050lbl.pdf

All Note Details

Original Tweet

All Information

  • noteId - 1636817640566947841
  • participantId -
  • raterParticipantId - 45B8EF43682258D990F1C39DD9C1C131E030B7B116A1A874CAD37AED55F98C04
  • createdAtMillis - 1679083489815
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 1
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 1
  • ratingsId - 163681764056694784145B8EF43682258D990F1C39DD9C1C131E030B7B116A1A874CAD37AED55F98C04